These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide. Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets. Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135 [TBL] [Abstract][Full Text] [Related]
4. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. Colotta F; Peri G; Villa A; Mantovani A J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624 [TBL] [Abstract][Full Text] [Related]
6. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. Kasahara T; Djeu JY; Dougherty SF; Oppenheim JJ J Immunol; 1983 Nov; 131(5):2379-85. PubMed ID: 6195261 [TBL] [Abstract][Full Text] [Related]
7. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells. Mandler RN; Biddison WE; Mandler R; Serrate SA J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481 [TBL] [Abstract][Full Text] [Related]
8. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones. van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399 [TBL] [Abstract][Full Text] [Related]
9. IFN-beta production by macrophages obtained from mice undergoing graft vs host disease. Cleveland MG; Ramirez RB; Klimpel GR J Immunol; 1988 Dec; 141(11):3823-7. PubMed ID: 2846694 [TBL] [Abstract][Full Text] [Related]
10. Human peripheral blood null lymphocytes stimulated by Staphylococcus aureus Cowan I produce atypical acid-labile interferon in vitro. Funa K; Ramstedt U; Rönnblom L; Alm GV Scand J Immunol; 1985 Jan; 21(1):55-62. PubMed ID: 2578690 [TBL] [Abstract][Full Text] [Related]
11. Phenotype of human alpha-interferon producing leucocytes identified by monoclonal antibodies. Abb J; Abb H; Deinhardt F Clin Exp Immunol; 1983 Apr; 52(1):179-84. PubMed ID: 6574829 [TBL] [Abstract][Full Text] [Related]
12. Killer-helper effect of L cells in the generation of anti-MM cytotoxic T lymphocytes: replacement by beta-interferon and mechanisms of action. Ishikawa S; Tachibana T Jpn J Cancer Res; 1986 Sep; 77(9):931-40. PubMed ID: 2945807 [TBL] [Abstract][Full Text] [Related]
13. A distinct population of nonphagocytic and low level CD4+ null lymphocytes produce IFN-alpha after stimulation by herpes simplex virus-infected cells. Sandberg K; Matsson P; Alm GV J Immunol; 1990 Aug; 145(3):1015-20. PubMed ID: 1695643 [TBL] [Abstract][Full Text] [Related]
14. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells. Frey JR; Kamber M; Peck R Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569 [TBL] [Abstract][Full Text] [Related]
15. Induction by interferon-alpha of tumoricidal activity of adherent mononuclear cells from human blood: monocytes as responder and effector cells. Sone S; Utsugi T; Shirahama T; Ishii K; Mutsuura S; Ogawara M J Biol Response Mod; 1985 Apr; 4(2):134-40. PubMed ID: 3998764 [TBL] [Abstract][Full Text] [Related]